Bio Path Stock Forecast - Period Momentum Indicator

BPTH Stock  USD 0.82  0.02  2.50%   
Bio Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Bio Path's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
As of now, Bio Path's Inventory Turnover is decreasing as compared to previous years. The Bio Path's current Receivables Turnover is estimated to increase to 6.19, while Payables Turnover is projected to decrease to 0.37. . The current Common Stock Shares Outstanding is estimated to decrease to about 292.6 K. The current Net Loss is estimated to decrease to about (9.9 M).
Bio Path Holdings has current Period Momentum Indicator of 0.02. Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.
Check Bio Path VolatilityBacktest Bio PathInformation Ratio  

Bio Path Trading Date Momentum

On November 22 2024 Bio Path Holdings was traded for  0.82  at the closing time. The top price for the day was 0.87  and the lowest listed price was  0.75 . The trading volume for the day was 34.2 K. The trading history from November 22, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.44% .
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare Bio Path to competition

Other Forecasting Options for Bio Path

For every potential investor in Bio, whether a beginner or expert, Bio Path's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bio. Basic forecasting techniques help filter out the noise by identifying Bio Path's price trends.

View Bio Path Related Equities

 Risk & Return  Correlation

Bio Path Holdings Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Bio Path's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Bio Path's current price.

Bio Path Market Strength Events

Market strength indicators help investors to evaluate how Bio Path stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Path shares will generate the highest return on investment. By undertsting and applying Bio Path stock market strength indicators, traders can identify Bio Path Holdings entry and exit signals to maximize returns.

Bio Path Risk Indicators

The analysis of Bio Path's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bio Path's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Bio Path Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Path's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Path Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Path Holdings Stock:
Check out Historical Fundamental Analysis of Bio Path to cross-verify your projections.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Path. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Path listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(8.34)
Return On Assets
(1.40)
Return On Equity
(3.66)
The market value of Bio Path Holdings is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Path's value that differs from its market value or its book value, called intrinsic value, which is Bio Path's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Path's market value can be influenced by many factors that don't directly affect Bio Path's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Path's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Path is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Path's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.